Navigation Links
Herborium Group, Inc. Announces No Disruptions From Hurricane Sandy
Date:11/5/2012

FORT LEE, N.J., Nov. 5, 2012 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink: HBRM) www.herborium.com, a Botanical Therapeutics® Company is happy to inform investors that the company operations have not been disrupted by hurricane Sandy. At the same time management thanks all of those who have expressed their concerns for the well being of our people and the company.

"Optimized business model and pure luck had kept Herborium out of the major impact of Sandy," stated Dr. Agnes P. Olszewski, Herborium's CEO and Chairwoman.

"We are moving forward with preparations to launch our unique all herbal energy formula Lasting Energy®.  This launch is especially important in light of recent serious problems and ongoing investigation of caffeine, sugar and Vit. B-Complex based energy products," Added Dr. Olszewski.

"We are also continuing our aggressive marketing of AcnEase®, proprietary all herbal acne treatment already present on the markets of North America, Europe, Australia and Asia.

"We will update investors on latest developments related to advancement of Lasting Energy® and AcnEase® the week of November 12th ," Concluded Dr. Olszewski. 

Once again thank you to all who have been concern about us, and our hearts go out to victims of Sandy.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage.  The company sells its products in the US and Europe. For more information on the company and its products, please visit www.herborium.com,  www.acnease.com and www.herboriumsh.com.

One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com


'/>"/>
SOURCE Herborium Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Herborium Group Achieves Major Milestones While Making Significant Progress On All Fronts Of Marketing Its Products
2. Herborium Group Reports Record 6 Month Revenues
3. Herborium Announces Continuing Progress In Key Strategic Initiatives
4. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
5. Watson Announces Sale of Rugby OTC Product Trademark and Assets to Major Pharmaceuticals, a division of The Harvard Drug Group, LLC
6. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
7. Rivalz Sports Group, Inc Sportstalk Station WRSO 810 AM Orlando Officially Takes Over And Goes Live With Sports Programming
8. Huntzinger Management Group, Inc., (HMG) Reporting Significant Growth in 2012
9. The SSI Group, Inc. President and CEO Bobby Smith Announces Retirement
10. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
11. MEI Pharma Announces $27.5 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology:
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):